Behzad Heidari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Behzad Heidari has a total of 63 co-authors. Here are the top co-authors by number of shared publications:
Mansour Babaei
Mobility Impairment Research Center, Babol University of Medical Sciences, Babol, Iran
7 shared publications- Yahya Javadian
Department of Physiotherapy, Babol University of Medical Sciences, Babol, Iran
5 shared publications - Karimollah Hajian-Tilaki
Dept of Biostatistics and Epidemiology, School of Public Health, Babol University of Medical Sciences, Babol, Iran
3 shared publications - Mansour Babaei
Babol Univ Med Sci, Ayatollah Rouhani Hosp, Mobil Impairment Res Ctr, Dept Rheumatol,Clin Res Dev Unit, Babol, Iran
3 shared publications - Mansour Babaei
Clinical Research Development Unit of Rouhani Hospital, Babol University of Medical Sciences
3 shared publications Parnaz Heidari
Sina Clin Hosp, Babol, Iran
3 shared publications
Latest Publications
- 10 February 2026
- Published by AVES YAYINCILIK A.Ş. in Endocrinology Research and Practice
Association of Vitamin D Status with Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study from Iran
Objective: Diabetic retinopathy (DR) is a major microvascular complication of type 2 diabetes mellitus (T2DM). In addition to hyperglycemia, vitamin D may influence DR via anti-inflammatory and anti-angiogenic mechanisms. This study examined the relationship between serum vitamin D levels and the presence and severity of DR, while accounting for clinical, biochemical, and lifestyle factors. Methods: A total of 120 patients with T2DM attending an ophthalmology clinic participated in this cross-sectional study. The presence of DR was determined through fundus photography and established DR criteria (ETDRS). Data included serum 25(OH)D, hemoglobin A1c (HbA1c), cholesterol, and clinical data. Patients were divided according to DR status as either DR or non-DR and further classified as non-proliferative diabetic retinopathy or proliferative diabetic retinopathy (PDR). Results: Compared to non-DR patients, those with DR had lower mean serum vitamin D levels (19.43 ± 4.50 ng/mL vs. 26.48 ± 8.99 ng/mL, P < .001). Diabetic retinopathy was associated with longer duration of diabetes and higher HbA1c and cholesterol. Patients with DR and PDR were more susceptible to vitamin D deficiency and were less likely to receive supplemental vitamin D. In a stepwise-adjusted multivariate regression model, low vitamin D and longer duration were independent predictors of DR. The risk of DR was also associated with a history of smoking and insulin therapy. Conclusion: Vitamin D deficiency is strongly associated with DR in Iranian patients with T2DM. Further research should clarify vitamin D’s potential as a modifiable risk factor for prevention strategies. Cite this article as: Zamani F, Babaei M, Heidari B, Bayani MA, Gholinia H, Rasoulinejad SA. Association of vitamin D status with diabetic retinopathy in patients with type 2 diabetes mellitus: A cross-sectional study from Iran. Endocrinol Res Pract. Published online February 6, 2026. doi: 10.5152/erp.2026.25812.
- 10 February 2026
- Published by AVES YAYINCILIK A.Ş. in Endocrinology Research and Practice
Association of Vitamin D Status with Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study from Iran
Objective: Diabetic retinopathy (DR) is a major microvascular complication of type 2 diabetes mellitus (T2DM). In addition to hyperglycemia, vitamin D may influence DR via anti-inflammatory and anti-angiogenic mechanisms. This study examined the relationship between serum vitamin D levels and the presence and severity of DR, while accounting for clinical, biochemical, and lifestyle factors. Methods: A total of 120 patients with T2DM attending an ophthalmology clinic participated in this cross-sectional study. The presence of DR was determined through fundus photography and established DR criteria (ETDRS). Data included serum 25(OH)D, hemoglobin A1c (HbA1c), cholesterol, and clinical data. Patients were divided according to DR status as either DR or non-DR and further classified as non-proliferative diabetic retinopathy or proliferative diabetic retinopathy (PDR). Results: Compared to non-DR patients, those with DR had lower mean serum vitamin D levels (19.43 ± 4.50 ng/mL vs. 26.48 ± 8.99 ng/mL, P < .001). Diabetic retinopathy was associated with longer duration of diabetes and higher HbA1c and cholesterol. Patients with DR and PDR were more susceptible to vitamin D deficiency and were less likely to receive supplemental vitamin D. In a stepwise-adjusted multivariate regression model, low vitamin D and longer duration were independent predictors of DR. The risk of DR was also associated with a history of smoking and insulin therapy. Conclusion: Vitamin D deficiency is strongly associated with DR in Iranian patients with T2DM. Further research should clarify vitamin D’s potential as a modifiable risk factor for prevention strategies. Cite this article as: Zamani F, Babaei M, Heidari B, Bayani MA, Gholinia H, Rasoulinejad SA. Association of vitamin D status with diabetic retinopathy in patients with type 2 diabetes mellitus: A cross-sectional study from Iran. Endocrinol Res Pract. Published online February 6, 2026. doi: 10.5152/erp.2026.25812.
- Open Access
- 19 October 2025
- Vol. 16 (4) , 686-691
Association between osteoporosis and symptomatic knee osteoarthritis in postmenopausal women: A case-control study
Postmenopausal women with symptomatic knee osteoarthritis (KOA) may be at increased risk of bone loss due to reduced physical activity. However, findings on the association between KOA and osteoporosis have been inconsistent. This study aimed to assess the relationship between symptomatic KOA and bone mineral density (BMD) in postmenopausal women. Postmenopausal women with symptomatic KOA were recruited from a rheumatology clinic. KOA was diagnosed according to the American College of Rheumatology (ACR) criteria. Age-matched postmenopausal women without clinical KOA served as controls. BMD at the femoral neck (FN) and lumbar spine (LS) was measured using dual-energy X-ray absorptiometry (DXA). Osteoporosis was defined as a T-score < -2.5 at either site. Statistical analyses included Student’s t-test, chi-square test, and multiple regression analysis. Data were analyzed using SPSS software. Seventy participants (35 KOA patients and 35 controls) with mean ages of 61.9±8.7 and 58.8±6.8 years, respectively (P = 0.67), were included. No significant differences in BMD were found between the groups. However, multiple regression analysis revealed that obesity was significantly associated with a reduced risk of osteoporosis (OR = 0.23; 95% CI: 0.058–0.945). This study found no significant association between symptomatic KOA and osteoporosis in postmenopausal women. Interestingly, obesity appeared to have a protective effect against osteoporosis. Further large-scale, long-term studies are needed to confirm these findings and explore underlying mechanisms.
- 19 October 2025
- Vol. 16 (4) , 686-691
Open AccessAssociation between osteoporosis and symptomatic knee osteoarthritis in postmenopausal women: A case-control study
Postmenopausal women with symptomatic knee osteoarthritis (KOA) may be at increased risk of bone loss due to reduced physical activity. However, findings on the association between KOA and osteoporosis have been inconsistent. This study aimed to assess the relationship between symptomatic KOA and bone mineral density (BMD) in postmenopausal women. Postmenopausal women with symptomatic KOA were recruited from a rheumatology clinic. KOA was diagnosed according to the American College of Rheumatology (ACR) criteria. Age-matched postmenopausal women without clinical KOA served as controls. BMD at the femoral neck (FN) and lumbar spine (LS) was measured using dual-energy X-ray absorptiometry (DXA). Osteoporosis was defined as a T-score < -2.5 at either site. Statistical analyses included Student’s t-test, chi-square test, and multiple regression analysis. Data were analyzed using SPSS software. Seventy participants (35 KOA patients and 35 controls) with mean ages of 61.9±8.7 and 58.8±6.8 years, respectively (P = 0.67), were included. No significant differences in BMD were found between the groups. However, multiple regression analysis revealed that obesity was significantly associated with a reduced risk of osteoporosis (OR = 0.23; 95% CI: 0.058–0.945). This study found no significant association between symptomatic KOA and osteoporosis in postmenopausal women. Interestingly, obesity appeared to have a protective effect against osteoporosis. Further large-scale, long-term studies are needed to confirm these findings and explore underlying mechanisms.
- 1 September 2024
- Published by Bentham Science Publishers Ltd. in Infectious Disorders - Drug Targets
- Vol. 24 (6) , 1-6
Factors Associated with Mortality in Patients with Coronavirus Disease (COVID-19) in Babol, North of Iran
Background: The spectrum of the clinical features of coronavirus disease 2019 (COVID-19) spans from asymptomatic or mild disease to severe respiratory failure, while different factors are related to its mortality rate. This research aimed to determine the clinical and laboratory characteristics and the associated factors of mortality in patients with COVID-19. Background: The spectrum of the clinical features of coronavirus disease 2019 (COVID-19) spans from asymptomatic or mild disease to severe respiratory failure, while different factors are related to its mortality rate. This research aimed to determine the clinical and laboratory characteristics and the associated factors of mortality in patients with COVID-19. Materials and Methods: Data were collected from hospitalized patients (May to June 2020), and COVID-19 was confirmed in patients by real-time polymerase chain reaction (PCR). The patient group was classified into survivor and deceased groups. The chi-square and the independent t-test with Statistical Package for the Social Sciences (SPSS) software program, version 18, were used for analysis. Results: Mean age, hemoglobin, serum C-reactive protein (CRP), alkaline phosphatase (ALP), white blood cells, and level of procalcitonin in non-survivors were significantly higher than in survivors. Serum tumour necrosis factor-alpha (TNF-a) had a significant relationship with D-dimer (p = 0.0006). The risk of mortality in patients with serum CRP > 100 mg/dl was significantly higher than those with CRP < 100 mg/dl (odds ratio (OR) = 4.8 (95 % CI, 1.33-12.44, p = 0.01). Conclusion: COVID-19 has different clinical features and can be an asymptomatic, mild, or severe disease. Thus, findings about the disease and the consequent outcomes differ in patients. Further studies are needed to evaluate the clinical features and consequences of COVID-19 infection.
- 1 September 2024
- Published by Bentham Science Publishers Ltd. in Infectious Disorders - Drug Targets
- Vol. 24 (6) , 1-6
Factors Associated with Mortality in Patients with Coronavirus Disease (COVID-19) in Babol, North of Iran
Background: The spectrum of the clinical features of coronavirus disease 2019 (COVID-19) spans from asymptomatic or mild disease to severe respiratory failure, while different factors are related to its mortality rate. This research aimed to determine the clinical and laboratory characteristics and the associated factors of mortality in patients with COVID-19. Background: The spectrum of the clinical features of coronavirus disease 2019 (COVID-19) spans from asymptomatic or mild disease to severe respiratory failure, while different factors are related to its mortality rate. This research aimed to determine the clinical and laboratory characteristics and the associated factors of mortality in patients with COVID-19. Materials and Methods: Data were collected from hospitalized patients (May to June 2020), and COVID-19 was confirmed in patients by real-time polymerase chain reaction (PCR). The patient group was classified into survivor and deceased groups. The chi-square and the independent t-test with Statistical Package for the Social Sciences (SPSS) software program, version 18, were used for analysis. Results: Mean age, hemoglobin, serum C-reactive protein (CRP), alkaline phosphatase (ALP), white blood cells, and level of procalcitonin in non-survivors were significantly higher than in survivors. Serum tumour necrosis factor-alpha (TNF-a) had a significant relationship with D-dimer (p = 0.0006). The risk of mortality in patients with serum CRP > 100 mg/dl was significantly higher than those with CRP < 100 mg/dl (odds ratio (OR) = 4.8 (95 % CI, 1.33-12.44, p = 0.01). Conclusion: COVID-19 has different clinical features and can be an asymptomatic, mild, or severe disease. Thus, findings about the disease and the consequent outcomes differ in patients. Further studies are needed to evaluate the clinical features and consequences of COVID-19 infection.
- 28 September 2023
- Published by LLC Science and Innovations in Russian Open Medical Journal
- Vol. 12 (3)
How Different Is The Status Of Depression And Anxiety In Patients With Rheumatoid Arthritis Receiving Methotrexate With Sulfasalazine Or Hydroxychloroquine?
Background — Depression and anxiety are among the most common clinical manifestations in patients with rheumatoid arthritis (RA). Sulfasalazine and hydroxychloroquine are important medications used to treat these patients. Objective — The goal of this study was to compare the occurrence of depression and anxiety in RA patients taking sulfasalazine or hydroxychloroquine for at least six months. Methods — This study included 300 patients with RA referred to inpatient or outpatient departments of a public hospital in northern Iran who were treated with two combination regimens of methotrexate and sulfasalazine or methotrexate and hydroxychloroquine. Participants were assessed on the standard Hospital Anxiety and Depression Scale (HADS) for symptoms of depression and anxiety. Results — The mean HADS depression subscale score was 6.77±3.98 in the hydroxychloroquine group and 3.50±3.53 in the sulfasalazine group (p<0.001). The mean HADS anxiety subscale score was 7.66±4.43 in the hydroxychloroquine group and 5.34±4.35 in the sulfasalazine group (p<0.001). Multiple linear regression analysis revealed a significant difference in the incidence of depression and anxiety between the two treatment groups. Conclusion — A higher prevalence of depression and anxiety was observed in RA patients treated with methotrexate and hydroxychloroquine versus those treated with methotrexate with sulfasalazine.
- 28 September 2023
- Published by LLC Science and Innovations in Russian Open Medical Journal
- Vol. 12 (3)
How Different Is The Status Of Depression And Anxiety In Patients With Rheumatoid Arthritis Receiving Methotrexate With Sulfasalazine Or Hydroxychloroquine?
Background — Depression and anxiety are among the most common clinical manifestations in patients with rheumatoid arthritis (RA). Sulfasalazine and hydroxychloroquine are important medications used to treat these patients. Objective — The goal of this study was to compare the occurrence of depression and anxiety in RA patients taking sulfasalazine or hydroxychloroquine for at least six months. Methods — This study included 300 patients with RA referred to inpatient or outpatient departments of a public hospital in northern Iran who were treated with two combination regimens of methotrexate and sulfasalazine or methotrexate and hydroxychloroquine. Participants were assessed on the standard Hospital Anxiety and Depression Scale (HADS) for symptoms of depression and anxiety. Results — The mean HADS depression subscale score was 6.77±3.98 in the hydroxychloroquine group and 3.50±3.53 in the sulfasalazine group (p<0.001). The mean HADS anxiety subscale score was 7.66±4.43 in the hydroxychloroquine group and 5.34±4.35 in the sulfasalazine group (p<0.001). Multiple linear regression analysis revealed a significant difference in the incidence of depression and anxiety between the two treatment groups. Conclusion — A higher prevalence of depression and anxiety was observed in RA patients treated with methotrexate and hydroxychloroquine versus those treated with methotrexate with sulfasalazine.
- Open Access
- 31 May 2022
- Published by Maad Rayan Publishing Company in Journal of Renal Injury Prevention
- Vol. 11 (3)
Highly sensitive C-reactive protein, pentraxin-3 and mannose-binding lectin in patients with hemodialysis and their association with cardiovascular complications and mortality
Introduction: Cardiovascular disorder(CVD) is one of the most important comorbidities in patients with hemodialysis(HD). Several markers for kidney disease and kidney transplantation have been investigated. Objectives: This study aimed to evaluate the association between three inflammatory biomarkers including C-reactive protein (CRP), pentraxin 3 (PTX-3) and mannose-binding lectin (MBL) with CVD events and mortality in HD patients. Patients and Methods: This study was carried on patients with immunosuppressive therapy aged between 18-80 years with chronic renal failure undergoing HD. Patients were visited at baseline and every six month for 12 months. The levels of biomarkers and complications were recorded before, one week later and 2 months after transplantation. Echocardiography and calculation of ejection fraction(EF) were performed to determine the occurrence of CVD events. Results: Ninety patients with the mean age of 54.0±3.24 years were included. All biomarkers had significant area under the curve for accurate diagnosis between the patients with low EF (with a decreasing measure) and normal EF patients (p0.05). PTX-3 and MBL showed a significant correlation to detect CVD events (r=0.987; p<0.0001). Also, PTX-3 and MBL had significant correlations with hs-CRP (P<0.05). None of these markers had significant accuracy for prediction of mortality. Conclusion: Serum level of PTX-3 and MBL not only increase reactive protein, but also may be considered as diagnostic biomarkers for early detection of CVD events in patients with end stage renal disorders.
- 31 May 2022
- Published by Maad Rayan Publishing Company in Journal of Renal Injury Prevention
- Vol. 11 (3)
Open AccessHighly sensitive C-reactive protein, pentraxin-3 and mannose-binding lectin in patients with hemodialysis and their association with cardiovascular complications and mortality
Introduction: Cardiovascular disorder(CVD) is one of the most important comorbidities in patients with hemodialysis(HD). Several markers for kidney disease and kidney transplantation have been investigated. Objectives: This study aimed to evaluate the association between three inflammatory biomarkers including C-reactive protein (CRP), pentraxin 3 (PTX-3) and mannose-binding lectin (MBL) with CVD events and mortality in HD patients. Patients and Methods: This study was carried on patients with immunosuppressive therapy aged between 18-80 years with chronic renal failure undergoing HD. Patients were visited at baseline and every six month for 12 months. The levels of biomarkers and complications were recorded before, one week later and 2 months after transplantation. Echocardiography and calculation of ejection fraction(EF) were performed to determine the occurrence of CVD events. Results: Ninety patients with the mean age of 54.0±3.24 years were included. All biomarkers had significant area under the curve for accurate diagnosis between the patients with low EF (with a decreasing measure) and normal EF patients (p0.05). PTX-3 and MBL showed a significant correlation to detect CVD events (r=0.987; p<0.0001). Also, PTX-3 and MBL had significant correlations with hs-CRP (P<0.05). None of these markers had significant accuracy for prediction of mortality. Conclusion: Serum level of PTX-3 and MBL not only increase reactive protein, but also may be considered as diagnostic biomarkers for early detection of CVD events in patients with end stage renal disorders.
- Open Access
- 1 January 2022
- Vol. 13 (2) , 326-334
Accuracy of obesity indices alone or in combination for prediction of diabetes: A novel risk score by linear combination of general and abdominal measures of obesity
The predictive power of obesity measures varies according to the presence of coexistent measures. The present study aimed to determine the predictive power of combinations of obesity measures for diabetes by calculation of a linear risk score. Data from a population-based cross-sectional study of 994 representative samples of Iranian adults in Babol, Iran were analyzed. Measures of obesity including waist circumference (WC), body mass index (BMI), waist–to–height ratio (WHtR), and waist to hip ratio (WHR) were calculated, and diabetes was diagnosed by fasting blood sugar >126 mg/dl or taking antidiabetic medication. Multiple logistic regression model was used to develop a logit risk score based on BMI, WC, WHtR, and WHR. The ROC analysis was applied to determine the priority of every single index and combined logit score for the prediction of diabetes. All four measures of general and abdominal obesity were predictors of diabetes individually in both sexes (P=0.0001). Calculation of risk score for a combination of all measures use full model improved predictive power. Adjustment for age resulted in further improvement in diagnostic power and combined novel risk score differentiated individuals with and without diabetes with an accuracy of 0.747 (95%CI: 0.690-0.808) in men and 0.789 (95%CI: 0.740, 0.837) in women. These findings indicate that the simultaneous calculation of age-adjusted risk score for all measures provides stronger diagnostic accuracy in both sexes. This issue suggests the calculation of combined risk scores for all obesity indices especially in a population at borderline risk.
- 1 January 2022
- Vol. 13 (2) , 326-334
Open AccessAccuracy of obesity indices alone or in combination for prediction of diabetes: A novel risk score by linear combination of general and abdominal measures of obesity
The predictive power of obesity measures varies according to the presence of coexistent measures. The present study aimed to determine the predictive power of combinations of obesity measures for diabetes by calculation of a linear risk score. Data from a population-based cross-sectional study of 994 representative samples of Iranian adults in Babol, Iran were analyzed. Measures of obesity including waist circumference (WC), body mass index (BMI), waist–to–height ratio (WHtR), and waist to hip ratio (WHR) were calculated, and diabetes was diagnosed by fasting blood sugar >126 mg/dl or taking antidiabetic medication. Multiple logistic regression model was used to develop a logit risk score based on BMI, WC, WHtR, and WHR. The ROC analysis was applied to determine the priority of every single index and combined logit score for the prediction of diabetes. All four measures of general and abdominal obesity were predictors of diabetes individually in both sexes (P=0.0001). Calculation of risk score for a combination of all measures use full model improved predictive power. Adjustment for age resulted in further improvement in diagnostic power and combined novel risk score differentiated individuals with and without diabetes with an accuracy of 0.747 (95%CI: 0.690-0.808) in men and 0.789 (95%CI: 0.740, 0.837) in women. These findings indicate that the simultaneous calculation of age-adjusted risk score for all measures provides stronger diagnostic accuracy in both sexes. This issue suggests the calculation of combined risk scores for all obesity indices especially in a population at borderline risk.
- Open Access
- 1 January 2022
- Vol. 13 (Suppl 3) , 211-220
Clinical, demographic, and laboratory characteristics of COVID -19 infection and risk of in-hospital mortality. A single center 4
Background: Despite advances in preventive measures, COVID-19 spread and mortality is continuing due to delay in timely diagnosis. This problem is partly dependent on variations in disease characteristics, distribution of risk factors particularly comorbidities and demographic characteristics of patients. This study aimed to determine the clinical presentation and associated factors of mortality in patients hospitalized with COVID-19 infection. Methods: Patients were divided into survivor and deceased groups, and clinical and laboratory findings and factors associated with mortality between the two groups were compared by calculating odds ratio (OR) with 95% confidence interval (95% CI). Results: A total of 257 patients (female 45.1%) with a mean age of 59.8+15.7 years and a mean hospital stay of 4.89+3.57 days were studied. Diabetes, hypertension, cardiovascular disease and chronic renal disease (CRD) were found in 29.6%, 37.5%, 16.3% and 3.5% of all patients, respectively. Forty-one (16%) patients died. Factors such as age 50 years, coexisting CRD, serum creatinine >= 2 mg/dl; SPO2 <70% lymphocytes < 20% during hospitalization were independently associated with mortality. The adjusted ORs (95% CI) were 10.08 (1.39-73); 4.51(1.15-17.61); 6 (1.14-31.5); 16.8(2.93-96.7); and 4.9(1.31-18.1), respectively. Most of the expected effective drugs were not associated with lower mortality. Conclusion: These results indicate a high in-hospital mortality rate in COVID-19 patients. Some mortality factors occurring during hospitalization were reversible and could be prevented by timely diagnosis and appropriate treatment.
- 1 January 2022
- Vol. 13 (Suppl 3) , 211-220
Open AccessClinical, demographic, and laboratory characteristics of COVID -19 infection and risk of in-hospital mortality. A single center 4
Background: Despite advances in preventive measures, COVID-19 spread and mortality is continuing due to delay in timely diagnosis. This problem is partly dependent on variations in disease characteristics, distribution of risk factors particularly comorbidities and demographic characteristics of patients. This study aimed to determine the clinical presentation and associated factors of mortality in patients hospitalized with COVID-19 infection. Methods: Patients were divided into survivor and deceased groups, and clinical and laboratory findings and factors associated with mortality between the two groups were compared by calculating odds ratio (OR) with 95% confidence interval (95% CI). Results: A total of 257 patients (female 45.1%) with a mean age of 59.8+15.7 years and a mean hospital stay of 4.89+3.57 days were studied. Diabetes, hypertension, cardiovascular disease and chronic renal disease (CRD) were found in 29.6%, 37.5%, 16.3% and 3.5% of all patients, respectively. Forty-one (16%) patients died. Factors such as age 50 years, coexisting CRD, serum creatinine >= 2 mg/dl; SPO2 <70% lymphocytes < 20% during hospitalization were independently associated with mortality. The adjusted ORs (95% CI) were 10.08 (1.39-73); 4.51(1.15-17.61); 6 (1.14-31.5); 16.8(2.93-96.7); and 4.9(1.31-18.1), respectively. Most of the expected effective drugs were not associated with lower mortality. Conclusion: These results indicate a high in-hospital mortality rate in COVID-19 patients. Some mortality factors occurring during hospitalization were reversible and could be prevented by timely diagnosis and appropriate treatment.
- Open Access
- 1 January 2021
- Published by Convin SA in Mediterranean Journal of Rheumatology
- Vol. 32 (3) , 227-236
Prevention of Osteoarthritis Progression by Statins, Targeting Metabolic and Inflammatory Aspects: A Review
Several traditional risk factors of atherosclerosis such as age, obesity, and altered lipid metabolism are shared with osteoarthritis (OA). Metabolic abnormalities and atheromatous vascular disease are linked with systemic inflammation and progression of OA. Hence, treatment of OA with statins is expected to improve metabolic abnormalities and prevent OA progression. Many studies which have addressed this issue found inconsistent results. This review aims to elucidate the effect of statins in OA by summarizing the existing data. Potential studies in English language published in Medline/PubMed, Scopus and Google Scholar since 2000 were searched by using keywords such as osteoarthritis, statins, progression, treatment, prevalence, synovitis, pain. Fourteen papers were found to be relevant and were summarised. Data regarding symptomatic effect of statins in OA are scarce and the results varied from no effect to a small improvement or even increased risk of pain in knee OA. However, most studies on the incidence and progression of OA found a significant decreased risk of incident OA, as well as reduced risk of radiographic progression in statin users vs. non-users. Factors such as patient adherence, duration of treatment, and higher cumulative statin doses were associated with greater efficacy. Existing data indicate a preventing effect of statin therapy on OA progression. However, unless a formal meta-analysis with weight analysis is made, a conclusion cannot be drawn.
- 1 January 2021
- Published by Convin SA in Mediterranean Journal of Rheumatology
- Vol. 32 (3) , 227-236
Open AccessPrevention of Osteoarthritis Progression by Statins, Targeting Metabolic and Inflammatory Aspects: A Review
Several traditional risk factors of atherosclerosis such as age, obesity, and altered lipid metabolism are shared with osteoarthritis (OA). Metabolic abnormalities and atheromatous vascular disease are linked with systemic inflammation and progression of OA. Hence, treatment of OA with statins is expected to improve metabolic abnormalities and prevent OA progression. Many studies which have addressed this issue found inconsistent results. This review aims to elucidate the effect of statins in OA by summarizing the existing data. Potential studies in English language published in Medline/PubMed, Scopus and Google Scholar since 2000 were searched by using keywords such as osteoarthritis, statins, progression, treatment, prevalence, synovitis, pain. Fourteen papers were found to be relevant and were summarised. Data regarding symptomatic effect of statins in OA are scarce and the results varied from no effect to a small improvement or even increased risk of pain in knee OA. However, most studies on the incidence and progression of OA found a significant decreased risk of incident OA, as well as reduced risk of radiographic progression in statin users vs. non-users. Factors such as patient adherence, duration of treatment, and higher cumulative statin doses were associated with greater efficacy. Existing data indicate a preventing effect of statin therapy on OA progression. However, unless a formal meta-analysis with weight analysis is made, a conclusion cannot be drawn.
- Open Access
- 23 December 2020
- Published by Termedia Sp. z.o.o. in Rheumatology
- Vol. 58 (6) , 424-435
Efficacy and predictive factors of response to intra-articular corticosteroids in knee osteoarthritis
In knee osteoarthritis (KOA), synovial inflammation is linked with pain, swelling and structural abnormalities. Intra-articular corticosteroids (IACS) have been considered for pain relief in subjects who are non-responders to standard therapy. However, the results vary across different studies. This review aims to determine efficacy of IACS in KOA by review of the existing data. In several randomized controlled trials (RCTs), meta-analyses and uncontrolled studies a single IACS resulted in pain relief from 1 to a few weeks. In a few studies repeated IACS every three months provided a longer duration of pain relief and functional improvement in a proportion of patients. Baseline synovitis was predictor of treatment response in some but not all studies. Based upon the existing data, IACS provides a short-term pain relief in a proportion of patients. Given, anti-inflammatory properties of IACS, it is likely to be more effective in subgroups of KOA who display inflammatory phenotype.
- 23 December 2020
- Published by Termedia Sp. z.o.o. in Rheumatology
- Vol. 58 (6) , 424-435
Open AccessEfficacy and predictive factors of response to intra-articular corticosteroids in knee osteoarthritis
In knee osteoarthritis (KOA), synovial inflammation is linked with pain, swelling and structural abnormalities. Intra-articular corticosteroids (IACS) have been considered for pain relief in subjects who are non-responders to standard therapy. However, the results vary across different studies. This review aims to determine efficacy of IACS in KOA by review of the existing data. In several randomized controlled trials (RCTs), meta-analyses and uncontrolled studies a single IACS resulted in pain relief from 1 to a few weeks. In a few studies repeated IACS every three months provided a longer duration of pain relief and functional improvement in a proportion of patients. Baseline synovitis was predictor of treatment response in some but not all studies. Based upon the existing data, IACS provides a short-term pain relief in a proportion of patients. Given, anti-inflammatory properties of IACS, it is likely to be more effective in subgroups of KOA who display inflammatory phenotype.
- 1 July 2020
- Published by Elsevier in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- Vol. 14 (4) , 435-442
Effectiveness and safety of routine calcium supplementation in postmenopausal women. A narrative review
- 1 July 2020
- Published by Elsevier in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- Vol. 14 (4) , 435-442
Effectiveness and safety of routine calcium supplementation in postmenopausal women. A narrative review